SG11201811796SA - Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same - Google Patents

Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same

Info

Publication number
SG11201811796SA
SG11201811796SA SG11201811796SA SG11201811796SA SG11201811796SA SG 11201811796S A SG11201811796S A SG 11201811796SA SG 11201811796S A SG11201811796S A SG 11201811796SA SG 11201811796S A SG11201811796S A SG 11201811796SA SG 11201811796S A SG11201811796S A SG 11201811796SA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
same
optically active
phenol derivative
pyranochromenyl phenol
Prior art date
Application number
SG11201811796SA
Other languages
English (en)
Inventor
Sang Ku Yoo
Jin Wook Chung
In Geun Jo
Ji Young Kim
Jeong Ho Im
Ku Suk Kang
Jin Young Kim
Original Assignee
Glaceum Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum Inc filed Critical Glaceum Inc
Publication of SG11201811796SA publication Critical patent/SG11201811796SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201811796SA 2016-06-29 2017-06-29 Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same SG11201811796SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160081674 2016-06-29
PCT/KR2017/006863 WO2018004263A1 (ko) 2016-06-29 2017-06-29 광학 활성 피라노크로메닐페놀 유도체 및 그를 포함하는 약학적 조성물

Publications (1)

Publication Number Publication Date
SG11201811796SA true SG11201811796SA (en) 2019-02-27

Family

ID=60787377

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201811796SA SG11201811796SA (en) 2016-06-29 2017-06-29 Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same

Country Status (17)

Country Link
US (2) US20190152984A1 (zh)
EP (2) EP4023651B1 (zh)
JP (2) JP2019520381A (zh)
KR (1) KR102388965B1 (zh)
CN (1) CN109476676B (zh)
AU (1) AU2017287746B2 (zh)
BR (1) BR112018077392A2 (zh)
CA (1) CA3028954C (zh)
DK (1) DK4023651T3 (zh)
ES (2) ES2929931T3 (zh)
IL (1) IL263826B2 (zh)
MX (1) MX2018016361A (zh)
PL (2) PL3480200T3 (zh)
SG (1) SG11201811796SA (zh)
TW (1) TWI731998B (zh)
WO (1) WO2018004263A1 (zh)
ZA (1) ZA201900121B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3524609T (pt) * 2016-10-04 2021-07-15 Glaceum Inc Método para a preparação de derivados de 3-fenil- 2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros óticos dos mesmos, e intermediários do processo
KR20200105198A (ko) 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
WO2022260434A1 (ko) 2021-06-08 2022-12-15 주식회사 글라세움 자가면역 질환의 예방 또는 치료용 약학적 조성물
KR20240078928A (ko) * 2022-11-28 2024-06-04 가톨릭대학교 산학협력단 침샘 오가노이드 안정화 및 침샘조직 재생 유도 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1599602A (zh) * 2001-10-11 2005-03-23 钟渊化学工业株式会社 过氧化物酶体增殖剂应答性受体配体剂及其制备方法
TW200513194A (en) * 2003-07-31 2005-04-16 Kaneka Corp Fat and oil processed composition for prevention and/or amelioration of life-style related disease
WO2007058480A1 (en) 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
KR102344479B1 (ko) * 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
KR101742274B1 (ko) 2014-12-31 2017-06-01 주식회사 과학기술분석센타 소규모 상수시설 통합 관리 시스템의 수질 측정 장치
PT3524609T (pt) * 2016-10-04 2021-07-15 Glaceum Inc Método para a preparação de derivados de 3-fenil- 2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros óticos dos mesmos, e intermediários do processo

Also Published As

Publication number Publication date
AU2017287746B2 (en) 2020-04-09
KR102388965B1 (ko) 2022-04-22
US20210094967A1 (en) 2021-04-01
JP2020186259A (ja) 2020-11-19
TWI731998B (zh) 2021-07-01
EP4023651B1 (en) 2023-09-13
JP7036871B2 (ja) 2022-03-15
DK4023651T3 (da) 2023-11-20
EP3480200A4 (en) 2020-02-26
WO2018004263A1 (ko) 2018-01-04
ES2964146T3 (es) 2024-04-04
US20190152984A1 (en) 2019-05-23
BR112018077392A2 (pt) 2019-04-09
PL3480200T3 (pl) 2023-01-30
CA3028954C (en) 2020-10-27
IL263826B2 (en) 2023-05-01
CN109476676A (zh) 2019-03-15
JP2019520381A (ja) 2019-07-18
TW201808961A (zh) 2018-03-16
EP3480200B1 (en) 2022-10-19
IL263826A (en) 2019-01-31
AU2017287746A1 (en) 2019-01-17
CA3028954A1 (en) 2018-01-04
KR20180002539A (ko) 2018-01-08
MX2018016361A (es) 2019-09-16
NZ749461A (en) 2020-08-28
EP3480200A1 (en) 2019-05-08
US11332475B2 (en) 2022-05-17
EP4023651A1 (en) 2022-07-06
ZA201900121B (en) 2023-04-26
PL4023651T3 (pl) 2024-02-19
CN109476676B (zh) 2021-09-17
IL263826B1 (en) 2023-01-01
ES2929931T3 (es) 2022-12-05

Similar Documents

Publication Publication Date Title
SG11201811796SA (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
WO2015106269A3 (en) Rapid action insulin formulations and pharmaceutical delivery systems
WO2015165413A8 (zh) 一种新型的稳定型抗体药物耦联物及其制备方法和用途
MX2020000333A (es) Formulaciones de conjugado anticuerpo anti-egfr-farmaco.
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
EP3845241A8 (en) Long lasting effect of new botulinum toxin formulations
WO2012103038A3 (en) Nanoparticle compositions, formulations thereof, and uses therefor
WO2017127835A3 (en) Aqueous formulations and methods of preparation and use thereof
MY190011A (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
EP4173615A3 (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
BR112018016729A2 (pt) novo composto de tiofeno substituído nas posições 2,3,5, utilizado como inibidor de proteína quinase
HRP20211824T1 (hr) Modulatori aktivnosti komplementa
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
WO2013171764A3 (en) Ophthalmic formulations
EA201690323A1 (ru) Способы лечения заболеваний уха у детей
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
WO2015048188A8 (en) Modified fibroblast growth factors for the treatment of ocular disorders
WO2015048503A3 (en) N-arylmethyl sulfonamide negative modulators of nr2a
EP3701970A4 (en) IMMUNITY STIMULATION AGENT, IMMUNOTHERAPEUTIC ANTI-CANCER AGENT, AND ADVERSE ANTI-CANCER THERAPY MITIGATION AGENT CONTAINING ANTHOCYANINE-FUCOIDANE COMPLEX AS ACTIVE INGREDIENT
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
MX2018009948A (es) Formulaciones de oritavancina.
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
WO2014116015A3 (ko) 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법